Company Valuation: Psychemedics Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Market Cap 1 50.48 28.13 38.91 27.69 17.17 13.68
Change - -44.28% 38.31% -28.84% -37.97% -20.34%
Enterprise Value (EV) 1 49.16 34.2 42.04 26.51 17.51 13.43
Change - -30.44% 22.93% -36.94% -33.96% -23.29%
P/E 32.7x -7.27x -58.5x -25.5x -4.09x -7x
PBR 3x 2.25x 3.2x 2.59x 2.58x 2.67x
PEG - 0x 0.7x -0.4x -0x 0.1x
Capitalization / Revenue 1.34x 1.32x 1.56x 1.1x 0.78x 0.69x
EV / Revenue 1.3x 1.6x 1.69x 1.05x 0.79x 0.68x
EV / EBITDA 7.91x -9.17x 16.7x -30.8x -12.5x -15.3x
EV / EBIT 12.9x -5.64x 201x -9.2x -5.99x -7.09x
EV / FCF 9.54x -9.36x 9.09x 4.85x 18.9x 7.91x
FCF Yield 10.5% -10.7% 11% 20.6% 5.29% 12.6%
Dividend per Share 2 0.72 0.18 0.05 0.28 0.07 -
Rate of return 7.87% 3.54% 0.71% 5.71% 2.36% -
EPS 2 0.2797 -0.7 -0.12 -0.1927 -0.7237 -0.32
Distribution rate 257% -25.7% -41.7% -145% -9.67% -
Net sales 1 37.68 21.36 24.91 25.24 22.1 19.68
EBITDA 1 6.215 -3.73 2.51 -0.86 -1.402 -0.876
EBIT 1 3.798 -6.066 0.209 -2.883 -2.921 -1.893
Net income 1 1.542 -3.859 -0.665 -1.084 -4.154 -1.861
Net Debt 1 -1.316 6.069 3.135 -1.176 0.334 -0.251
Reference price 2 9.150 5.090 7.020 4.905 2.960 2.240
Nbr of stocks (in thousands) 5,517 5,526 5,542 5,645 5,802 6,107
Announcement Date 2/25/20 3/26/21 3/30/22 3/27/23 3/28/24 3/24/25
1USD in Million2USD
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 15.24M
-163.66x13.59x-185.39x-.--% 39.05B
19x1.85x10.66x1.06% 22.61B
17.16x1.34x7.6x5.07% 7.39B
321.95x - - - 4.94B
49.5x8.81x31.31x1.05% 3.03B
-18.66x - - - 1.85B
-31.93x - - -.--% 1.85B
31.15x1.11x9.27x0.81% 1.79B
35.16x1.65x13.07x1.46% 1.85B
Average 28.85x 4.73x -18.91x 1.35% 8.44B
Weighted average by Cap. -48.22x 8.11x -89.89x 0.89%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. PMDI Stock
  4. Valuation Psychemedics Corporation